Omnichannel Drug Launch in Pharma: AI Insights for Biosimilars

Why an Omnichannel Drug Launch Matters for Biosimilars

Biosimilars often face steep barriers:
– Market scepticism. HCPs may doubt efficacy or interchangeability.
– Fragmented messaging. Sales, medical and digital teams often operate in silos.
– Complex channels. Email, social media, microsites, congress booths… where to start?

An effective omnichannel drug launch:

1. Aligns messaging across every touchpoint.
2. Segments HCPs by behaviour and mindset.
3. Adapts campaign assets in real time.

The payoff? Faster adoption, deeper engagement, and a stronger formulary presence.

Competitor Spotlight: Amplity’s Omnichannel Approach

Amplity AskX has helped mid-sized biopharma craft unified launches. Their method includes:

• HCP segmentation by knowledge, channel preference and behaviour.
• Tailored scientific content for different personas.
• Multi-channel deployment: email, social media communities, microsites, congress presentations, video and sales tools.
• Real-time analysis of field feedback to tweak messages on the fly.

Strengths of Amplity AskX:

• Rich HCP insights through surveys and interviews.
• A proven case study: a biosimilar achieved the second-highest therapeutic volume among seven products in Q1 post-launch.
• 100% sales team engagement and over 3,000 HCPs reached in under 12 months.

The Limitations of Amplity AskX

Despite its success, AskX has gaps:

• Reliance on manual HCP interviews can slow down feedback loops.
• Content deployment often needs coordination across multiple tools.
• Limited predictive analytics—teams learn what works after launch, not before.
• Challenges scaling in multiple European markets with differing regulations and languages.

These gaps leave room for a platform that can blend real-time AI, predictive forecasting and seamless channel orchestration.

Introducing Smart Launch: AI-Driven Insights at Every Step

Smart Launch from ConformanceX is designed for modern biosimilar launches. It tackles those limitations head-on:

1. Real-time data fusion
   – Integrates field feedback, prescribing trends, social media chatter and regulatory updates.
   – Uses machine learning to spot emerging adoption barriers within hours, not weeks.

2. Predictive analytics
   – Forecasts market uptake in different regions and specialties.
   – Ranks high-value HCP segments most likely to adopt a biosimilar.
   – Minimises risk by simulating “what-if” scenarios before spend is committed.

3. Unified omnichannel orchestration
   – Centralises email campaigns, social media posts, microsite updates and sales toolkits.
   – Automatically adjusts content based on engagement metrics.
   – Supports localisation for multiple European markets—language, compliance and channel preference.

4. Competitive intelligence
   – Monitors rival biosimilar launches in real time.
   – Tracks competitor messaging shifts, pricing moves and clinical trial announcements.
   – Alerts teams to gaps and opportunities before they become headlines.

Smart Launch vs Amplity AskX: Feature Comparison

Best Practices for an AI-Empowered Omnichannel Drug Launch

Whether you choose AskX or Smart Launch, these tips will boost your campaign:

1. Start with a clear segmentation framework
   – Define HCP clusters by specialty, prescribing habits and digital behaviour.
   – Use AI to refine those segments as new data arrives.

2. Develop modular content
   – Create small “content blocks” (data points, KOL quotes, clinical bulletins).
   – Mix and match for emails, videos, microsites and sales tools.

3. Leverage predictive insights
   – Test copy variations on small HCP subsets.
   – Deploy the top-performing variant at scale.

4. Automate feedback loops
   – Connect CRM, social listening and field-reporting tools.
   – Trigger alerts for under-performing regions or messages.

5. Maintain compliance and localisation
   – Build approval workflows into your omnichannel platform.
   – Localise translations and regulatory disclaimers automatically.

Why Smart Launch Is the Edge You Need

You want more than just a launch. You need lasting adoption and formulary success. With Smart Launch you gain:

• A holistic view of market dynamics.
• The agility to adjust in mid-campaign.
• AI-powered risk mitigation through predictive scenarios.
• Deep competitive insights to stay a step ahead.

Your next biosimilar deserves more than guesswork. It deserves an omnichannel drug launch solution built for today’s digital-first, data-driven world.

Ready to experience the future of biosimilar launches?
Start your free trial or get a personalised demo of Smart Launch today.

Visit us at ConformanceX and take the first step towards a smarter, smoother, more successful launch.